Labcorp Holdings annual total debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Total Debt Growth & History (LH)
Labcorp Holdings's total debt was $6.53B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.53B | −$746.8M | −10.27% |
| 2024 | 2024-12-31 | $7.27B | $1.32B | +22.15% |
| 2023 | 2023-12-31 | $5.95B | −$292.2M | −4.68% |
| 2022 | 2022-12-31 | $6.25B | −$96.2M | −1.52% |
| 2021 | 2021-12-31 | $6.34B | −$413.8M | −6.12% |
| 2020 | 2020-12-31 | $6.76B | −$351.2M | −4.94% |
| 2019 | 2019-12-31 | $7.11B | $1.01B | +16.57% |
| 2018 | 2018-12-31 | $6.10B | −$775.1M | −11.28% |
| 2017 | 2017-12-31 | $6.87B | $911.3M | +15.29% |
| 2016 | 2016-12-31 | $5.96B | −$507.4M | −7.84% |
| 2015 | 2015-12-31 | $6.47B | $3.37B | +108.97% |
| 2014 | 2014-12-31 | $3.10B | $65.8M | +2.17% |
| 2013 | 2013-12-31 | $3.03B | $374.7M | +14.11% |
| 2012 | 2012-12-31 | $2.65B | $434.0M | +19.54% |
| 2011 | 2011-12-31 | $2.22B | $32.6M | +1.49% |
| 2010 | 2010-12-31 | $2.19B | $794.0M | +56.94% |
| 2009 | 2009-12-31 | $1.39B | −$326.9M | −18.99% |
| 2008 | 2008-12-31 | $1.72B | — | — |
Labcorp Holdings quarterly total debt
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.77B | $719.7M | +11.90% |
| Q1 2026 | 2026-03-31 | $7.24B | $721.4M | +11.07% |
| Q4 2025 | 2025-12-31 | $6.53B | −$746.8M | −10.27% |
| Q3 2025 | 2025-09-30 | $6.03B | −$289.2M | −4.58% |
| Q2 2025 | 2025-06-30 | $6.05B | $2.09B | +52.86% |
| Q1 2025 | 2025-03-31 | $6.52B | $2.59B | +66.01% |
| Q4 2024 | 2024-12-31 | $7.27B | $1.32B | +22.15% |
| Q3 2024 | 2024-09-30 | $6.32B | $980.3M | +18.36% |
| Q2 2024 | 2024-06-30 | $3.96B | −$1.95B | −33.06% |
| Q1 2024 | 2024-03-31 | $3.93B | −$2.06B | −34.44% |
| Q4 2023 | 2023-12-31 | $5.95B | −$292.2M | −4.68% |
| Q3 2023 | 2023-09-30 | $5.34B | −$930.5M | −14.84% |
| Q2 2023 | 2023-06-30 | $5.91B | −$405.3M | −6.42% |
| Q1 2023 | 2023-03-31 | $5.99B | −$300.2M | −4.77% |
| Q4 2022 | 2022-12-31 | $6.25B | −$96.2M | −1.52% |
| Q3 2022 | 2022-09-30 | $6.27B | −$64.5M | −1.02% |
| Q2 2022 | 2022-06-30 | $6.31B | −$41.6M | −0.65% |
| Q1 2022 | 2022-03-31 | $6.29B | $431.1M | +7.36% |
| Q4 2021 | 2021-12-31 | $6.34B | −$413.8M | −6.12% |
| Q3 2021 | 2021-09-30 | $6.33B | −$349.9M | −5.24% |
| Q2 2021 | 2021-06-30 | $6.36B | −$758.1M | −10.66% |
| Q1 2021 | 2021-03-31 | $5.86B | −$1.26B | −17.68% |
| Q4 2020 | 2020-12-31 | $6.76B | −$351.2M | −4.94% |
| Q3 2020 | 2020-09-30 | $6.68B | −$754.0M | −10.14% |
| Q2 2020 | 2020-06-30 | $7.11B | −$393.1M | −5.24% |
| Q1 2020 | 2020-03-31 | $7.12B | $298.1M | +4.37% |
| Q4 2019 | 2019-12-31 | $7.11B | $1.01B | +16.57% |
| Q3 2019 | 2019-09-30 | $7.44B | $914.8M | +14.02% |
| Q2 2019 | 2019-06-30 | $7.51B | $987.9M | +15.15% |
| Q1 2019 | 2019-03-31 | $6.82B | −$21.3M | −0.31% |
| Q4 2018 | 2018-12-31 | $6.10B | −$775.1M | −11.28% |
| Q3 2018 | 2018-09-30 | $6.52B | −$763.1M | −10.47% |
| Q2 2018 | 2018-06-30 | $6.52B | $329.4M | +5.32% |
| Q1 2018 | 2018-03-31 | $6.84B | $856.9M | +14.32% |
| Q4 2017 | 2017-12-31 | $6.87B | $911.3M | +15.29% |
| Q3 2017 | 2017-09-30 | $7.29B | $1.04B | +16.74% |
| Q2 2017 | 2017-06-30 | $6.19B | $67.2M | +1.10% |
| Q1 2017 | 2017-03-31 | $5.98B | −$479.3M | −7.42% |
| Q4 2016 | 2016-12-31 | $5.96B | −$507.4M | −7.84% |
| Q3 2016 | 2016-09-30 | $6.24B | −$497.2M | −7.38% |
| Q2 2016 | 2016-06-30 | $6.12B | −$723.0M | −10.56% |
| Q1 2016 | 2016-03-31 | $6.46B | −$541.0M | −7.72% |
| Q4 2015 | 2015-12-31 | $6.47B | $3.37B | +108.97% |
| Q3 2015 | 2015-09-30 | $6.74B | $3.70B | +121.53% |
| Q2 2015 | 2015-06-30 | $6.85B | $3.81B | +125.87% |
| Q1 2015 | 2015-03-31 | $7.00B | $3.98B | +131.47% |
| Q4 2014 | 2014-12-31 | $3.10B | $65.8M | +2.17% |
| Q3 2014 | 2014-09-30 | $3.04B | $377.9M | +14.19% |
| Q2 2014 | 2014-06-30 | $3.03B | $520.8M | +20.75% |
| Q1 2014 | 2014-03-31 | $3.03B | $703.1M | +30.27% |
| Q4 2013 | 2013-12-31 | $3.03B | $374.7M | +14.11% |
| Q3 2013 | 2013-09-30 | $2.66B | $3.8M | +0.14% |
| Q2 2013 | 2013-06-30 | $2.51B | $400.3M | +18.98% |
| Q1 2013 | 2013-03-31 | $2.32B | $201.5M | +9.50% |
| Q4 2012 | 2012-12-31 | $2.65B | $434.0M | +19.54% |
| Q3 2012 | 2012-09-30 | $2.66B | $676.5M | +34.10% |
| Q2 2012 | 2012-06-30 | $2.11B | $106.3M | +5.31% |
| Q1 2012 | 2012-03-31 | $2.12B | −$83.3M | −3.78% |
| Q4 2011 | 2011-12-31 | $2.22B | $32.6M | +1.49% |
| Q3 2011 | 2011-09-30 | $1.98B | $637.6M | +47.37% |
| Q2 2011 | 2011-06-30 | $2.00B | $680.5M | +51.44% |
| Q1 2011 | 2011-03-31 | $2.20B | $876.4M | +65.98% |
| Q4 2010 | 2010-12-31 | $2.19B | $794.0M | +56.94% |
| Q3 2010 | 2010-09-30 | $1.35B | −$54.8M | −3.91% |
| Q2 2010 | 2010-06-30 | $1.32B | −$89.1M | −6.31% |
| Q1 2010 | 2010-03-31 | $1.33B | — | — |
| Q4 2009 | 2009-12-31 | $1.39B | −$326.9M | −18.99% |
| Q3 2009 | 2009-09-30 | $1.40B | — | — |
| Q2 2009 | 2009-06-30 | $1.41B | — | — |
| Q4 2008 | 2008-12-31 | $1.72B | — | — |
Labcorp Holdings total debt trends
Over the last five fiscal years, Labcorp Holdings's total debt decreased from $6.76B to $6.53B, a change of −$230.4M. The latest reported quarter, Q2 2026, shows $6.77B.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...